Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    0.00 (0.00%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Trading Statement

18 Apr 2016 07:00

RNS Number : 4175V
Creston PLC
18 April 2016
 

18 April 2016

 

Creston plc

('Creston' or the 'Group')

Trading update

 

Creston plc, the marketing communications group, provides an update on trading for the year ended 31 March 2016 ahead of its unaudited preliminary results for the period, which will be announced on Wednesday 8 June 2016.

 

The Board anticipates the Group's financial performance to be in line with the trading statement of January 2016 and consensus expectations for revenue, Headline PBT and Headline Diluted Earnings per Share, with net cash ahead of expectations at over £1 million. As previously announced, exceptional charges against reported PBT will include a charge for impairment in the carrying value of goodwill.

 

Barrie Brien, Group Chief Executive, commented: "We have ended the year in line with consensus expectations. The actions we have taken since our January update to the market, plus a more stable outlook for our clients, continue to develop our strong foundation for future growth."

 

 

For further information please contact:

Creston plc

+ 44 (0)20 7930 9757

Barrie Brien, Group Chief Executive

Kathryn Herrick, Chief Financial Officer

Bell Pottinger

+44 (0)20 3772 2491

Elly Williamson/Lucy Stewart

 

About Creston plc

Creston plc (LSE: CRE), incorporating the Creston Unlimited group offer, is a marketing communications group delivering a range of digital technology based marketing solutions to blue-chip global clients. Encompassing consultants and discipline experts from across the industry and beyond, Creston Unlimited unlocks the power of creative collaboration to realise the opportunities that exist for brands and businesses in today's rapidly evolving world.

www.creston.com

-----------------------------------___________________________________________________________________

[1] Headline results reflect the underlying performance of the Group and exclude property related costs, start-up net losses, acquisition and restructuring related costs, the launch of Creston Unlimited and Group rebranding, movement in fair value of contingent deferred consideration, impairment of goodwill, amortisation of acquired intangibles, deemed remuneration charges, acquisition related share based payment charges and notional finance costs.

2 Profit before taxation (PBT).

3 Like-for-like comparisons remove the impact of acquisitions during the current period.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUUWCUPQGQA
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.